Immunotherapy based on tumor-associated antigen-specific immune effector cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapy based on tumor-associated antigen-specific immune effector cells, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells [Phase 1, Phase 2]